245 related articles for article (PubMed ID: 32404936)
1. YAP1/TAZ drives ependymoma-like tumour formation in mice.
Eder N; Roncaroli F; Domart MC; Horswell S; Andreiuolo F; Flynn HR; Lopes AT; Claxton S; Kilday JP; Collinson L; Mao JH; Pietsch T; Thompson B; Snijders AP; Ultanir SK
Nat Commun; 2020 May; 11(1):2380. PubMed ID: 32404936
[TBL] [Abstract][Full Text] [Related]
2. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
Pajtler KW; Wei Y; Okonechnikov K; Silva PBG; Vouri M; Zhang L; Brabetz S; Sieber L; Gulley M; Mauermann M; Wedig T; Mack N; Imamura Kawasawa Y; Sharma T; Zuckermann M; Andreiuolo F; Holland E; Maass K; Körkel-Qu H; Liu HK; Sahm F; Capper D; Bunt J; Richards LJ; Jones DTW; Korshunov A; Chavez L; Lichter P; Hoshino M; Pfister SM; Kool M; Li W; Kawauchi D
Nat Commun; 2019 Sep; 10(1):3914. PubMed ID: 31477715
[TBL] [Abstract][Full Text] [Related]
3. Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells.
Abou Nader N; Charrier L; Meisnsohn MC; Banville L; Deffrennes B; St-Jean G; Boerboom D; Zamberlam G; Brind'Amour J; Pépin D; Boyer A
FASEB J; 2024 May; 38(9):e23633. PubMed ID: 38690712
[TBL] [Abstract][Full Text] [Related]
4. Nuclear condensates of YAP fusion proteins alter transcription to drive ependymoma tumourigenesis.
Hu X; Wu X; Berry K; Zhao C; Xin D; Ogurek S; Liu X; Zhang L; Luo Z; Sakabe M; Trubicka J; Łastowska M; Szulzewsky F; Holland EC; Lee L; Hu M; Xin M; Lu QR
Nat Cell Biol; 2023 Feb; 25(2):323-336. PubMed ID: 36732631
[TBL] [Abstract][Full Text] [Related]
5. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.
Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS
Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369
[TBL] [Abstract][Full Text] [Related]
6. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic characterization with somatic genome editing and gene transfer reveals the diverse oncogenicity of ependymoma fusion genes.
Takadera M; Satomi K; Szulzewsky F; Cimino PJ; Holland EC; Yamamoto T; Ichimura K; Ozawa T
Acta Neuropathol Commun; 2020 Nov; 8(1):203. PubMed ID: 33228790
[TBL] [Abstract][Full Text] [Related]
8. Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features.
Andreiuolo F; Varlet P; Tauziède-Espariat A; Jünger ST; Dörner E; Dreschmann V; Kuchelmeister K; Waha A; Haberler C; Slavc I; Corbacioglu S; Riemenschneider MJ; Leipold A; Rüdiger T; Körholz D; Acker T; Russo A; Faber J; Sommer C; Armbrust S; Rose M; Erdlenbruch B; Hans VH; Bernbeck B; Schneider D; Lorenzen J; Ebinger M; Handgretinger R; Neumann M; van Buiren M; Prinz M; Roganovic J; Jakovcevic A; Park SH; Grill J; Puget S; Messing-Jünger M; Reinhard H; Bergmann M; Hattingen E; Pietsch T
Brain Pathol; 2019 Mar; 29(2):205-216. PubMed ID: 30246434
[TBL] [Abstract][Full Text] [Related]
9. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
10. Loss of TAZ after YAP deletion severely impairs foregut development and worsens cholestatic hepatocellular injury.
Gabdulkhakova A; Krutsenko Y; Zhu J; Liu S; Poddar M; Singh S; Ma X; Nejak-Bowen K; Monga SPS; Molina LM
Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37556373
[TBL] [Abstract][Full Text] [Related]
11. YAP1/TAZ-TEAD transcriptional networks maintain skin homeostasis by regulating cell proliferation and limiting KLF4 activity.
Yuan Y; Park J; Feng A; Awasthi P; Wang Z; Chen Q; Iglesias-Bartolome R
Nat Commun; 2020 Mar; 11(1):1472. PubMed ID: 32193376
[TBL] [Abstract][Full Text] [Related]
12. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis.
Zheng M; Li RG; Song J; Zhao X; Tang L; Erhardt S; Chen W; Nguyen BH; Li X; Li M; Wang J; Evans SM; Christoffels VM; Li N; Wang J
Circulation; 2022 Nov; 146(22):1694-1711. PubMed ID: 36317529
[TBL] [Abstract][Full Text] [Related]
13. YAP1 and TAZ negatively control bone angiogenesis by limiting hypoxia-inducible factor signaling in endothelial cells.
Sivaraj KK; Dharmalingam B; Mohanakrishnan V; Jeong HW; Kato K; Schröder S; Adams S; Koh GY; Adams RH
Elife; 2020 Jan; 9():. PubMed ID: 31958058
[TBL] [Abstract][Full Text] [Related]
14. Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population.
Liu R; Wei C; Ma Q; Wang W
Pregnancy Hypertens; 2020 Jan; 19():1-10. PubMed ID: 31841877
[TBL] [Abstract][Full Text] [Related]
15. C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
Parker M; Mohankumar KM; Punchihewa C; Weinlich R; Dalton JD; Li Y; Lee R; Tatevossian RG; Phoenix TN; Thiruvenkatam R; White E; Tang B; Orisme W; Gupta K; Rusch M; Chen X; Li Y; Nagahawhatte P; Hedlund E; Finkelstein D; Wu G; Shurtleff S; Easton J; Boggs K; Yergeau D; Vadodaria B; Mulder HL; Becksfort J; Gupta P; Huether R; Ma J; Song G; Gajjar A; Merchant T; Boop F; Smith AA; Ding L; Lu C; Ochoa K; Zhao D; Fulton RS; Fulton LL; Mardis ER; Wilson RK; Downing JR; Green DR; Zhang J; Ellison DW; Gilbertson RJ
Nature; 2014 Feb; 506(7489):451-5. PubMed ID: 24553141
[TBL] [Abstract][Full Text] [Related]
16. The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number.
Lavado A; Park JY; Paré J; Finkelstein D; Pan H; Xu B; Fan Y; Kumar RP; Neale G; Kwak YD; McKinnon PJ; Johnson RL; Cao X
Dev Cell; 2018 Dec; 47(5):576-591.e8. PubMed ID: 30523785
[TBL] [Abstract][Full Text] [Related]
17. TEAD4, YAP1 and WWTR1 prevent the premature onset of pluripotency prior to the 16-cell stage.
Frum T; Watts JL; Ralston A
Development; 2019 Sep; 146(17):. PubMed ID: 31444221
[TBL] [Abstract][Full Text] [Related]
18. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
19. Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade.
Lodge EJ; Santambrogio A; Russell JP; Xekouki P; Jacques TS; Johnson RL; Thavaraj S; Bornstein SR; Andoniadou CL
Elife; 2019 Mar; 8():. PubMed ID: 30912742
[TBL] [Abstract][Full Text] [Related]
20. YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis.
He C; Lv X; Huang C; Hua G; Ma B; Chen X; Angeletti PC; Dong J; Zhou J; Wang Z; Rueda BR; Davis JS; Wang C
EMBO Rep; 2019 Mar; 20(3):. PubMed ID: 30755404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
